Skip to content

The efficacy and health economics evaluation of combined screening for multiple cancers: A multicenter prospective randomized controlled study

The efficacy and health economics evaluation of combined screening for multiple cancers: A multicenter prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106022
Enrollment
Unknown
Registered
2025-07-16
Start date
2025-07-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumor

Interventions

Multi-cancer screening group:Electronic gastrointestinal endoscopy (including pathological biopsy), lung CT, female breast ultrasound (BI-RADS classification) and abdominal ultrasound (for hepatitis B
Control group:Collection of basic information

Sponsors

The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. At the time of enrollment, the age of the subjects was between 45 and 74 years old; 2. Be willing and able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Have a history of malignant tumors in the past; 2. The screening benefits are reduced due to severe diseases, such as severe lung diseases, kidney diseases, liver diseases, cardiovascular and cerebrovascular diseases, and blood diseases, etc. 3. Other situations where doctors assess that endoscopic screening has excessive risks (such as hemodynamic instability) or no benefits (short life expectancy); 4. Pregnant or lactating women; 5. Unable to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
The total mortality rate of the six types of cancer (lung cancer, colorectal cancer, gastric cancer, liver cancer, breast cancer and esophageal cancer);

Secondary

MeasureTime frame
Detection rate of six cancers (lung, colorectal, gastric, liver, breast and esophageal) in the first screening;Rate of early detection of six cancers (lung, colorectal, gastric, liver, breast and esophageal) in the first screening program;

Countries

China

Contacts

Public ContactYanglin Pan

The First Affiliated Hospital of Air Force Military Medical University

zhengrong4956@163.com+86 198 2975 8242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026